Renaissance Technologies - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 1 filers reported holding VIRACTA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$154
-18.9%
148,199
+9.9%
0.00%
Q2 2023$190
-4.5%
134,799
+7.6%
0.00%
Q1 2023$199
-2.5%
125,299
-10.4%
0.00%
Q4 2022$204
-100.0%
139,787
+45.8%
0.00%
-100.0%
Q3 2022$409,000
+13.0%
95,899
+2.7%
0.00%
Q2 2022$362,000
+58.8%
93,399
+94.6%
0.00%
Q1 2022$228,000
-46.0%
48,000
-58.5%
0.00%
-100.0%
Q4 2021$422,000115,7000.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 288,571$421,3140.28%
BVF INC/IL 3,614,662$5,277,4070.22%
Samsara BioCapital, LLC 689,709$1,006,9750.22%
Rubric Capital Management LP 1,330,983$1,943,2350.08%
HAMILTON LANE ADVISORS LLC 35,791$520.02%
MAI Capital Management 426,916$623,2970.01%
Jasper Ridge Partners, L.P. 92,939$135,6910.01%
BOURGEON CAPITAL MANAGEMENT LLC 17,500$25,5500.01%
RP Management, LLC 3,700$5,4020.01%
Laurion Capital Management LP 698,000$1,019,0800.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders